Relationships between diabetes and cognitive impairment

Endocrinol Metab Clin North Am. 2014 Mar;43(1):245-67. doi: 10.1016/j.ecl.2013.09.006. Epub 2013 Dec 12.

Abstract

Epidemics of obesity, diabetes, nonalcoholic fatty liver disease, and cognitive impairment/Alzheimer disease have emerged over the past 3 to 4 decades. These diseases share in common target-organ insulin resistance with a constellation of molecular and biochemical abnormalities that lead to organ/tissue degeneration over time. This article discusses the fundamental links among these diseases and how peripheral organ insulin resistance diseases contribute to cognitive impairment and neurodegeneration. A future role of endocrinologists and diabetologists could be to provide integrative diagnostic and treatment approaches for this collection of diseases that seem to share pathophysiological and pathogenetic bases.

Keywords: Alzheimer disease; Cognitive impairment; Diabetes; Insulin resistance; Insulin sensitizers; Neurodegeneration; Obesity.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Aging / metabolism*
  • Brain / metabolism*
  • Cognition Disorders / classification
  • Cognition Disorders / etiology
  • Cognition Disorders / metabolism*
  • Diabetes Mellitus / classification
  • Diabetes Mellitus / etiology
  • Diabetes Mellitus / metabolism*
  • Humans
  • Metabolic Syndrome / classification
  • Metabolic Syndrome / etiology
  • Metabolic Syndrome / metabolism*